JOURNAL OF HEADACHE AND PAIN

Scope & Guideline

Fostering Collaboration in Headache and Pain Research

Introduction

Delve into the academic richness of JOURNAL OF HEADACHE AND PAIN with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1129-2369
PublisherBMC
Support Open AccessYes
CountryItaly
TypeJournal
Convergefrom 2001 to 2024
AbbreviationJ HEADACHE PAIN / J. Headache Pain
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The Journal of Headache and Pain focuses on disseminating research findings that advance the understanding, diagnosis, and treatment of headache disorders. The journal aims to cover a wide range of topics related to headache, including epidemiology, pathophysiology, clinical management, and novel therapeutic strategies.
  1. Epidemiology and Burden of Headache Disorders:
    Research that evaluates the prevalence, incidence, and socioeconomic impact of various headache types, including migraine, tension-type headaches, and cluster headaches.
  2. Pathophysiology and Mechanisms of Headache:
    Studies exploring the biological, neurological, and genetic underpinnings of headache disorders, including neuroinflammation, neurotransmitter pathways, and genetic susceptibility.
  3. Clinical Management and Treatment Strategies:
    Articles discussing pharmacological and non-pharmacological treatment approaches, including the use of monoclonal antibodies, neuromodulation techniques, and lifestyle interventions in headache management.
  4. Psychosocial and Quality of Life Aspects:
    Research investigating the psychological impact of headaches on patients, including comorbid conditions, mental health, and quality of life assessments.
  5. Innovative Diagnostic and Therapeutic Approaches:
    Papers focusing on advancements in diagnostic tools, imaging techniques, and emerging therapies for headache disorders.
  6. Global Perspectives on Headache Care:
    Research that addresses the disparities in headache care across different regions, including access to treatment and cultural factors influencing management.
The Journal of Headache and Pain is witnessing an increase in research focused on innovative approaches and contemporary issues in headache management. This section outlines the trending and emerging themes that are shaping the future of headache research.
  1. CGRP Pathway and Monoclonal Antibodies:
    There is a significant surge in research related to the calcitonin gene-related peptide (CGRP) pathway, with numerous studies assessing the efficacy and safety of CGRP monoclonal antibodies in migraine prevention and treatment.
  2. Telemedicine and Digital Health Solutions:
    The impact of telemedicine on headache management has gained traction, particularly following the COVID-19 pandemic, with research exploring the effectiveness of remote consultations and digital health interventions.
  3. Neuroinflammation and its Role in Headaches:
    Emerging studies are increasingly focusing on neuroinflammation as a critical factor in the pathophysiology of headaches, leading to a better understanding of chronic headache mechanisms.
  4. Psychological Aspects and Comorbidities:
    Research is trending towards understanding the interplay between psychological factors, such as anxiety and depression, and their impact on headache disorders, emphasizing the need for holistic management.
  5. Personalized and Precision Medicine Approaches:
    An increase in studies exploring personalized treatment strategies based on genetic, phenotypic, and psychosocial profiles of headache patients is becoming evident.

Declining or Waning

As the field of headache research evolves, certain themes appear to be less prevalent in recent publications compared to earlier years. This section highlights these waning scopes that may indicate shifts in research priorities or emerging trends.
  1. Traditional Pharmacological Treatments:
    There is a noticeable decrease in studies focused solely on traditional medications like triptans and analgesics, as newer therapies such as anti-CGRP monoclonal antibodies gain prominence in research.
  2. Non-Evidence-Based Treatments:
    Research on non-evidence-based or anecdotal treatments for headache disorders is less frequently published, reflecting a shift towards evidence-based medicine and clinical trials.
  3. Unidimensional Studies:
    There is a decline in studies that focus solely on one-dimensional aspects of headache without integrating psychosocial or multidimensional health outcomes.
  4. Overreliance on Retrospective Studies:
    A reduction in the number of retrospective studies as the field increasingly values prospective, randomized controlled trials and real-world evidence.

Similar Journals

NEUROLOGIC CLINICS

Elevating understanding through rigorous research.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8619Frequency: 4 issues/year

NEUROLOGIC CLINICS, published by W B SAUNDERS CO-ELSEVIER INC, stands as a leading journal in the field of clinical neurology, boasting an impressive impact factor that reflects its significant contributions to neurological research and clinical practice. With an ISSN of 0733-8619 and E-ISSN of 1557-9875, this journal provides a critical platform for the dissemination of innovative research, case studies, and reviews focusing on various aspects of neurology, from diagnosis to treatment interventions. As part of its commitment to advancing the understanding of neurological disorders, NEUROLOGIC CLINICS is categorized in the Q2 quartile for Neurology (clinical) in 2023, indicating its robust standing within the academic community. It is recognized for its rigorous peer-review process and is indexed in Scopus, ranking #147 out of 400 in its field with a notable 63rd percentile. The journal, which dates back to 1983 and continues to publish vital findings up to 2024, is an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing their knowledge and clinical skills in neurology. Subscribe now to stay abreast of current advancements and expand your expertise in this dynamic field.

Pulmonary Circulation

Exploring breakthroughs in respiratory medicine.
Publisher: WILEYISSN: 2045-8932Frequency: 4 issues/year

Pulmonary Circulation is a leading open-access journal published by Wiley, focused on advancing the field of pulmonary and respiratory medicine. Established in 2011, the journal has garnered a prestigious reputation, achieving a Q2 ranking in 2023 among its category and ranking #70 out of 155 in Scopus within the specialty of Medicine – Pulmonary and Respiratory Medicine, reflecting its growing influence and relevance in the scientific community. With its commitment to delivering high-quality, peer-reviewed research, Pulmonary Circulation serves as a vital resource for researchers, clinicians, and students seeking to explore innovative ideas and findings in lung health, pulmonary vascular diseases, and therapeutic approaches. The journal has been open access since 2017, ensuring that groundbreaking research is accessible to a wider audience, thus promoting collaboration and knowledge exchange in this dynamic field. Located in the heart of the United States at 111 River St, Hoboken, NJ 07030-5774, the journal is dedicated to fostering advancements in pulmonary health and addressing real-world challenges facing patients globally.

Neuropsychiatric Disease and Treatment

Advancing Neuropsychiatry Through Innovative Research
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

Neuropsychiatric Disease and Treatment, published by DOVE MEDICAL PRESS LTD, is a prominent open access journal dedicated to advancing the field of neuropsychiatry. Since its inception in 2009, this journal has provided a platform for the dissemination of high-quality research on innovative therapies and treatments for neuropsychiatric disorders. With an impressive Q2 ranking in Psychiatry and Mental Health and a Q3 ranking in Biological Psychiatry as of 2023, it holds a reputable position within the scholarly community, reflecting its commitment to impactful research. The journal's open access model ensures widespread accessibility, fostering collaboration and dialogue among researchers, clinicians, and students worldwide. The journal accepts a variety of article types, including original research, reviews, and case studies, encompassing a range of topics from pathophysiology to therapeutic advancements. With its base in New Zealand and a Scopus rank placing it within the 69th percentile of Psychiatry and Mental Health, Neuropsychiatric Disease and Treatment is an essential resource for those dedicated to understanding and treating the complexities of neuropsychiatric conditions.

EUROPEAN JOURNAL OF PAIN

Uncovering Insights, Enhancing Lives
Publisher: WILEYISSN: 1090-3801Frequency: 10 issues/year

The European Journal of Pain, published by Wiley, is a premier peer-reviewed journal specializing in the fields of Anesthesiology and Pain Medicine. With an impressive impact factor and a prestigious ranking in the Q1 category for both Anesthesiology and Pain Medicine, as well as Miscellaneous Medicine, this journal stands out in the academic landscape, significantly contributing to the understanding and treatment of pain across various patient populations. Operating since 1997 and continuing through 2024, the journal provides a platform for groundbreaking research, reviews, and clinical studies, making it an invaluable resource for researchers, practitioners, and students alike. While it operates under a subscription model, the rigorous peer-review process ensures that readers access high-quality, evidence-based content that is essential for the advancement of pain management and anesthetic practices globally.

Korean Journal of Pain

Shaping the future of anesthesia and pain management.
Publisher: KOREAN PAIN SOCISSN: 2005-9159Frequency: 4 issues/year

The Korean Journal of Pain is a distinguished open-access publication dedicated to advancing the field of pain management and anesthesia. Published by the Korean Pain Society, this journal has been a vital resource since 1988, contributing to significant advancements in clinical practice and research. With an impressive Q1 ranking in Anesthesiology and Pain Medicine, and a Scopus rank of #32 out of 136—placing it in the 76th percentile—this journal fosters high-quality scholarly communication among researchers and healthcare professionals. The journal's scope encompasses a wide range of topics related to pain, facilitating the exchange of knowledge crucial for both innovative research and effective clinical application. Located in Seoul, South Korea, it serves as an essential platform for publishing cutting-edge research, systematic reviews, and case reports, ensuring that the latest findings reach a global audience. Whether you are a researcher, clinician, or student, the Korean Journal of Pain is an indispensable resource for anyone dedicated to the study and treatment of pain.

HEADACHE

Pioneering Discoveries in Headache Treatment
Publisher: WILEYISSN: 0017-8748Frequency: 10 issues/year

HEADACHE is a premier academic journal dedicated to advancing the study of headache disorders through innovative research and clinical insights. Published by WILEY, this influential journal has been serving the neurology community since its inception in 1961 and is recognized as a leader in its field, boasting an impressive Q1 ranking in both Neurology and Neurology (clinical) categories for 2023. With a robust Scopus ranking of #48 in clinical neurology and #26 in neuroscience, HEADACHE consistently publishes high-quality research that contributes to the understanding and treatment of headache disorders worldwide. Although it does not offer open access options, the journal remains accessible to a wide audience through various institutional subscriptions. It aims to provide a platform for researchers, healthcare professionals, and students to exchange ideas and develop new strategies for headache management, making it an essential resource for those dedicated to improving patient outcomes in this challenging area of healthcare.

Journal of Pain Research

Empowering Global Research on Pain Solutions
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7090Frequency: 1 issue/year

Journal of Pain Research, published by DOVE MEDICAL PRESS LTD, stands at the forefront of the field of pain management and anesthesia, offering a critical platform for researchers and clinicians dedicated to advancing the understanding of pain and its treatment. With an Open Access model since 2008, this journal enhances accessibility to high-quality research, enabling a global audience to engage with innovative studies and findings. Recognized for its significant contributions, it has achieved a Q2 rank in Anesthesiology and Pain Medicine as of 2023, placing it among the top 30% in its category, and it holds a commendable Scopus rank of 41/136 in its field. Covering a broad scope encompassing clinical trials, pharmacology, and psychosocial aspects of pain, the journal invites submissions that advance both theoretical knowledge and practical applications, making it an invaluable resource for professionals, researchers, and students aiming to improve outcomes in pain management.

CURRENT OPINION IN NEUROLOGY

Illuminating Trends in Neurology and Beyond.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1350-7540Frequency: 6 issues/year

CURRENT OPINION IN NEUROLOGY is a premier academic journal dedicated to providing insightful overviews and critical analyses across all areas of neurology and clinical neurology. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an impressive impact factor, highlighting its influence and relevance in the field—positioning it in the Q1 category for both neurology and clinical neurology as of 2023. With its comprehensive coverage, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to stay abreast of the latest developments, trends, and breakthroughs in neurological science and practice. Though not open access, articles are available via institutional subscriptions or individual purchase, ensuring that vital research remains accessible to a wide audience. Covering research from its inception in 1993 to ongoing studies in 2024, CURRENT OPINION IN NEUROLOGY stands out as an essential platform for disseminating knowledge and fostering dialogue within the dynamic and evolving landscape of neurology.

NEUROLOGY

Fostering excellence in the study of neurological disorders.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0028-3878Frequency: 48 issues/year

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.

CEPHALALGIA

Pioneering Studies for Better Patient Outcomes
Publisher: SAGE PUBLICATIONS LTDISSN: 0333-1024Frequency: 14 issues/year

CEPHALALGIA is a prestigious peer-reviewed journal dedicated to the field of headache research and management, published by SAGE Publications Ltd. With a remarkable impact in the discipline, it holds the esteemed position of Q1 across both Medicine (miscellaneous) and Neurology (clinical) categories as of 2023, placing it in the top 10% of its field according to Scopus rankings. The journal has been actively contributing to the scientific community since 1981, offering a platform for groundbreaking studies, reviews, clinical guidelines, and original research articles that emphasize the complexities and multidimensional aspects of headache disorders. As a vital resource for clinicians, researchers, and students, CEPHALALGIA aims to enhance understanding and foster innovation in headache management, ultimately improving patient outcomes in this prevalent area of healthcare. Although it does not currently operate under an open access model, the journal's rigorous selection process ensures the publication of only the highest quality research, making it an essential reference for anyone serious about advancing knowledge in this critical domain.